MYND Life Sciences Inc. (CSE:MYND)
Canada
· Delayed Price · Currency is CAD 0.0700
0.00 (0.00%)
Apr 22, 2025, 5:08 PM EST
MYND Life Sciences Market Cap
MYND Life Sciences has a market cap or net worth of CAD 5.22 million as of March 9, 2026. Its market cap has increased by 31.13% in one year.
Market Cap
5.22M
Enterprise Value
8.22M
Revenue
1.00
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since May 26, 2021, MYND Life Sciences's market cap has decreased from 98.76M to 5.22M, a decrease of -94.72%. That is a compound annual growth rate of -52.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2025 | 5.22M | 9.13% |
| Dec 27, 2024 | 4.78M | 150.00% |
| Dec 22, 2023 | 1.91M | 2.14% |
| Dec 30, 2022 | 1.87M | -85.12% |
| Dec 31, 2021 | 12.58M | -87.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptose Biosciences | 5.59M |
| Quest PharmaTech | 5.92M |
| BioVaxys Technology | 4.41M |
| Kane Biotech | 6.36M |
| COSCIENS Biopharma | 6.40M |
| XORTX Therapeutics | 4.18M |
| MindBio Therapeutics | 3.84M |
| Restart Life Sciences | 7.11M |